Welcome to SAfAIDS
GENEVA, 24 March 2014 (UNAIDS) - On World Tuberculosis (TB) Day, UNAIDS is making an urgent call for global efforts to be stepped up to ensure earlier testing and treatment of TB and HIV. TB remains a leading cause of death among people living with HIV. In 2012, there were an estimated 1.1 million new cases of TB among people living with HIV—with 75% of new cases occurring among people living in Africa.
SAfAIDS joins the world in commemorating World TB Day on 24th March 2014. World TB Day is designed to build public awareness that today, tuberculosis remains an epidemic in much of the world, causing deaths of several million people each year, mostly in developing countries. Nearly nine million people fell ill with TB in 2010, with 1.4 million dying from the disease. Of these deaths, 95% were in developing countries.
HARARE, (SAfAIDS Media Desk) - “Maresults ako iwawo ndiwo anguwo”. Your HIV Test results are the same as mine! These were some of the beliefs the majority of men expressed at the recently held Men Demand Creation Community Dialogue (DCCD) and Demand Creation Leadership Dialogue (DCLD) held in Chivi under the theme ‘Our baby, Our Future” which had an attendance of over 120 men from various walks of life.
GABORONE, 19 March 2014 (BONELA) - In another important legal victory for human rights in Botswana, the High Court in Gaborone yesterday ordered the government to provide HIV treatment to all non-citizen prisoners.
Our Baby, Our Future- Time for action to safeguard our heritage! - Demand Creation Leadership Dialogues (DCLD) Promoting Leadership participation through DCLD
HARARE (SAfAIDS Media Desk) - Following recent media reports on the availability of Epikaizo, a purportedly new HIV herbal remedy, as an information centre of excellence in the southern African region, SAfAIDS would like to categorically make known its position regarding Epikaizo and other remedies that continue to mushroom on the market and encourage people living with HIV to stop taking their ARVs, or to mix their ARVs with the new treatments.